DK428089A - USING THE PLASMINOGEN ACTIVATOR INHIBITOR (PAI-2) FOR IMMUNE EXPRESSION - Google Patents

USING THE PLASMINOGEN ACTIVATOR INHIBITOR (PAI-2) FOR IMMUNE EXPRESSION

Info

Publication number
DK428089A
DK428089A DK428089A DK428089A DK428089A DK 428089 A DK428089 A DK 428089A DK 428089 A DK428089 A DK 428089A DK 428089 A DK428089 A DK 428089A DK 428089 A DK428089 A DK 428089A
Authority
DK
Denmark
Prior art keywords
pai
plasminogen activator
activator inhibitor
immune expression
immune
Prior art date
Application number
DK428089A
Other languages
Danish (da)
Other versions
DK428089D0 (en
Inventor
Thomas Stief
Norbert Heimburger
Hans Ulrich Schorlemmer
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of DK428089D0 publication Critical patent/DK428089D0/en
Publication of DK428089A publication Critical patent/DK428089A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

The possibility of using plasminogen activator inhibitor (PAI-2) for producing a medicament for immunosuppression is described. Also described is a medicament containing PAI-2 and an ornithine decarboxylase inhibitor.
DK428089A 1988-08-31 1989-08-30 USING THE PLASMINOGEN ACTIVATOR INHIBITOR (PAI-2) FOR IMMUNE EXPRESSION DK428089A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3829523A DE3829523A1 (en) 1988-08-31 1988-08-31 USE OF PLASMINOGEN ACTIVATOR INHIBITOR (PAI-2) FOR IMMUNE SUPPRESSION

Publications (2)

Publication Number Publication Date
DK428089D0 DK428089D0 (en) 1989-08-30
DK428089A true DK428089A (en) 1990-03-01

Family

ID=6361973

Family Applications (1)

Application Number Title Priority Date Filing Date
DK428089A DK428089A (en) 1988-08-31 1989-08-30 USING THE PLASMINOGEN ACTIVATOR INHIBITOR (PAI-2) FOR IMMUNE EXPRESSION

Country Status (9)

Country Link
EP (1) EP0356945B1 (en)
JP (1) JPH02108633A (en)
KR (1) KR900002791A (en)
AT (1) ATE97576T1 (en)
AU (1) AU616555B2 (en)
DE (2) DE3829523A1 (en)
DK (1) DK428089A (en)
ES (1) ES2061842T3 (en)
PT (1) PT91584B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4214215A1 (en) * 1992-04-30 1993-11-04 Behringwerke Ag USE OF INHIBITORS OF PLASMINOGEN ACTIVATORS FOR TREATING INFLAMMATION
WO1999049887A1 (en) * 1998-04-01 1999-10-07 Biotech Australia Pty. Limited Use of protease inhibitors for treating skin wounds
AUPP508798A0 (en) * 1998-08-05 1998-08-27 Biotech Australia Pty Limited Method of treating psoriasis
EP1066834A3 (en) * 1999-07-08 2004-06-02 Thomas Dr. Stief Pharmaceutical compositions comprising a phagocyte-modulating agent
AU1123001A (en) 1999-10-27 2001-05-08 Alexandra Lucas Compositions and methods for preventing and treating transplant rejection
AUPQ380699A0 (en) * 1999-11-02 1999-11-25 Biotech Australia Pty Limited Protease inhibitors as modulators of periodontal wound healing
AU2001291579B2 (en) 2000-09-29 2006-08-31 Viron Therapeutics Inc. Use of serp- 1 in combination with an immunosuppressant for influencing inflammatory and immune reactions
KR100550385B1 (en) * 2002-11-11 2006-02-08 메타볼랩(주) Inhibitor from Adhesion between Candida and Its Host Cell Comprising Transglutaminase as Active Ingredient
JP4578067B2 (en) * 2003-06-06 2010-11-10 宏 清水 Topical pharmaceutical composition
US7285530B2 (en) 2004-10-21 2007-10-23 Viron Therapeutics, Inc. Use of SERP-1 as an antiplatelet agent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923807A (en) * 1984-05-18 1990-05-08 New England Medical Center Hospitals Inc. Arg-Serpin human plasminogen activator inhibitor designated PAI-2
WO1986003973A1 (en) * 1985-01-14 1986-07-17 Terumo Kabushiki Kaisha Fibrinophilic urokinase complex and process for its preparation
DE3713272A1 (en) * 1987-04-18 1988-11-03 Behringwerke Ag Plasminogen activator inhibitor type 2 (PAI-2)
DE3829524A1 (en) * 1988-08-31 1990-03-01 Behringwerke Ag USE OF TRANSGLUTAMINASES AS IMMUNE SUPPRESSIVA

Also Published As

Publication number Publication date
AU4090589A (en) 1990-03-08
PT91584B (en) 1995-05-31
DK428089D0 (en) 1989-08-30
ES2061842T3 (en) 1994-12-16
EP0356945A3 (en) 1991-07-31
PT91584A (en) 1990-03-08
EP0356945A2 (en) 1990-03-07
DE3829523A1 (en) 1990-03-01
EP0356945B1 (en) 1993-11-24
DE58906241D1 (en) 1994-01-05
ATE97576T1 (en) 1993-12-15
JPH02108633A (en) 1990-04-20
KR900002791A (en) 1990-03-23
AU616555B2 (en) 1991-10-31

Similar Documents

Publication Publication Date Title
DK463989A (en) PHARMACEUTICAL ACTIVE COMBINATION
DE3686410D1 (en) STABILIZED COMPOSITIONS OF HUMAN ACTIVATORS OF TISSUE PLASMINOGEN.
FI872917A0 (en) PHARMACEUTICAL BAERARE, VILKA FRIGOER AKTIVAEMNET REGLERBART.
DK163173C (en) PROCEDURE FOR THE PREPARATION OF A LYOPHILIZED PHARMACEUTICAL PREPARATION OF TABLE PLASMINOGEN ACTIVATOR (T-PA)
DK428089A (en) USING THE PLASMINOGEN ACTIVATOR INHIBITOR (PAI-2) FOR IMMUNE EXPRESSION
ES2051695T3 (en) TREATMENT OF THROMBOSIS CONTAINING A FIBRINOLYTIC AND AN ANALOG OF CARBACICLINE.
DK427989A (en) USE OF TRANSGLUATAMINAS AS IMMUNOSUPPRESIVA
SE8803085L (en) DOSFORM FOR DELIVERING DILTIAZEM
DK427886D0 (en) PHARMACEUTICAL PREPARATIONS CONTAINING INHIBITORS OF ANGIOTENSIN-CONCENTRATING ENZYZE FOR TREATMENT OF HIGH BLOOD PRESSURE
NO933235D0 (en) Use of an Inhibitor for the Preparation of a Drug
JO1120B1 (en) N-(1-allye-2-pyrrolidiny-methyl)2methoxy-4-amino-5-methylsulfamoyl benzamide, its method of oreperation and its use as a medicament
DE59008693D1 (en) Tissue plasminogen activator derivative.
ES2033096T3 (en) MEDICINES CONTAINING TISSUE PLASMINOGEN ACTIVATOR.
UA7778A1 (en) 13-[(2s) 2-amino-4-carboxybutanoyl]-1,4,7,10-tetraoxa-13-azacyclopentadecane hydrochloride having antiamnesic and antihypoxic action
GR3003285T3 (en) Antiperspirants with alpha-2-adrenergic amine activity

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment